The Cancer Research Unit, Department of Biology,
University of York,
York. YO10 5DD. UK.
Tel: +44 (0) 1904 328711
Fax: +44 (0) 1904 328710
Miss Leanne Archer won 1st prize in the 2nd Year Biology Departmental PhD talks. The talk was entitled 'An Investigation into the Role of the ETS Factor ELF3 in Prostate Cancer'.
Successful Grant Applications (recently awarded):-
Prostate Cancer UK - PhD Studentship 'An investigation of the role of the ets factor ELF3 in prostate cancer agressiveness' 2014-2016.
Yorkshire Cancer Research Grant - 'Can we exploit microRNA expression patterns to improve the prognosis for prostate cancer patients?' 2014-2016, £170,349
Prostate Cancer UK Grant: Maitland, NJ. 'Functional analysis of the role of the stem cell control gene latexin in prostate cancer invasion and metastasis' 2014-2016, £192,658
Prostate Cancer UK Grant: Collins AT., Maitland NJ. ‘Targeting the tumour-initiating population in prostate cancer’ 2013-2016, £187,426
Guest Speaker Invitations 2015:-
Prof Norman Maitland was invited to the following:
Invited Talk and Judge for student presentations on Masters Course – University of Madrid, Spain - 7-9 December
Presented abstract – AACR Meeting, Development Biology & Cancer, Boston, USA 30 -3 December
Invited Talk – Stem Cell Symposium, London - 12 November
Invited talk - DUO 2015 Congress, Urological Oncology Meeting – San Sebastian, Spain - 29-30 October
Invited talk - employees from Depuy Synthes, Leeds - 28 October
Invited talk - Circulating Biomarkers Conference, Glasgow - 30-2 October
Talk and tour of the Cancer Research Unit Laboratory by York Prostate Support Group - 21 September
Invited Talk - Cancer Translational Research Group (CTRG) Annual Symposium, Queen’s University Belfast - 18 September
Invited Talk - eci 4th European Congress of Immunology Conference – Vienna - 6-9 September
Invited talk - York Probus Group - 3 September
Dr Fiona Frame was invited to the following:
Yorkshire Cancer Research Annual Research Meeting - Talk 'Could a clinically approved histone deacetylase (HDAC) inhibitor sensitise prostate cancer to radiotherapy?'- 2 July 2015
The Cancer Research Unit draws its research funding from a number of sources both local, National and International.